Erratum: Expression of concern: MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis (Nucleic Acids Research (2012) 40: 2 (761–774) DOI: 10.1093/nar/gkr730);MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis

Nucleic Acids Research

Volumn 40, Issue 2, 2012, Pages 761-774

  Xu, Qing ^a   Liu, Ling Zhi ^b   Qian, Xu ^a   Chen, Qi ^a   Jiang, Yue ^b   Li, Dan ^c   Lai, Lihui ^c   Jiang, Bing Hua ^a,b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c EAST CHINA NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; MICRORNA; MICRORNA 145; PROTEIN P70; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; NORTHERN BLOTTING; OVARY CANCER; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VASCULARIZATION; WESTERN BLOTTING;

EID: 84862908024     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkad202     Document Type: Erratum

References (56)

1. Lai, E. C. (2002) Micro RNAs are complementary to 30 UTR sequence motifs that mediate negative post-transcriptional regulation. Nat. Genet., 30, 363-364.
2. Lee, R. C. and Ambros, V. (2001) An extensive class of small RNAs in Caenorhabditis elegans. Science, 294, 862-864.
3. Ambros, V. (2001) microRNAs: tiny regulators with great potential. Cell, 107, 823-826.
4. Xu, N., Papagiannakopoulos, T., Pan, G., Thomson, J. A. and Kosik, K. S. (2009) MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell, 137, 647-658.
5. Le, S. C., Nagel, R., Egan, D. A., Schrier, M., Mesman, E., Mangiola, A., Anile, C., Maira, G., Mercatelli, N., Ciafre, S. A. et al. (2007) Regulation of the p27 (Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J., 26, 3699-3708.
6. Yoo, A. S., Staahl, B. T., Chen, L. and Crabtree, G. R. (2009) MicroRNA-mediated switching of chromatin-remodelling complexes in neural development. Nature, 460, 642-646.
7. Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M. et al. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl Acad. Sci. USA, 101, 2999-3004.
8. Zhang, H., Li, Y. and Lai, M. (2010) The microRNA network and tumor metastasis. Oncogene, 29, 937-948.
9. Iorio, M. V., Ferracin, M., Liu, C. G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M. et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res., 65, 7065-7070.
10. Iorio, M. V., Visone, R., Di, L. G., Donati, V., Petrocca, F., Casalini, P., Taccioli, C., Volinia, S., Liu, C. G., Alder, H. et al. (2007) MicroRNA signatures in human ovarian cancer. Cancer Res., 67, 8699-8707.
11. Liu, X., Sempere, L. F., Galimberti, F., Freemantle, S. J., Black, C., Dragnev, K. H., Ma, Y., Fiering, S., Memoli, V., Li, H. et al. (2009) Uncovering growth-suppressive MicroRNAs in lung cancer. Clin. Cancer Res., 15, 1177-1183.
12. Michael, M. Z., O'Connor, S. M., van Holst Pellekaan, N. G., Young, G. P. and James, R. J. (2003) Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol. Cancer Res., 1, 882-891.
13. Schaefer, A., Jung, M., Mollenkopf, H. J., Wagner, I., Stephan, C., Jentzmik, F., Miller, K., Lein, M., Kristiansen, G. and Jung, K. (2010) Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int. J. Cancer, 126, 1166-1176.
14. Takagi, T., Iio, A., Nakagawa, Y., Naoe, T., Tanigawa, N. and Akao, Y. (2009) Decreased expression of microRNA-143 and-145 in human gastric cancers. Oncology, 77, 12-21.
15. Chen, H. C., Chen, G. H., Chen, Y. H., Liao, W. L., Liu, C. Y., Chang, K. P., Chang, Y. S. and Chen, S. J. (2009) MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. Br. J. Cancer, 100, 1002-1011.
16. Ichimi, T., Enokida, H., Okuno, Y., Kunimoto, R., Chiyomaru, T., Kawamoto, K., Kawahara, K., Toki, K., Kawakami, K., Nishiyama, K. et al. (2009) Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int. J. Cancer, 125, 345-352.
17. Suzuki, H. I., Yamagata, K., Sugimoto, K., Iwamoto, T., Kato, S. and Miyazono, K. (2009) Modulation of microRNA processing by p53. Nature, 460, 529-533.
18. Cordes, K. R., Sheehy, N. T., White, M. P., Berry, E. C., Morton, S. U., Muth, A. N., Lee, T. H., Miano, J. M., Ivey, K. N. and Srivastava, D. (2009) miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature, 460, 705-710.
19. Folkman, J. (1971) Tumor angiogenesis: therapeutic implications. N. Engl. J. Med., 285, 1182-1186.
20. Plate, K. H., Breier, G., Weich, H. A. and Risau, W. (1992) Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature, 359, 845-848.
21. Leung, D. W., Cachianes, G., Kuang, W. J., Goeddel, D. V. and Ferrara, N. (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science, 246, 1306-1309.
22. Wang, G. L., Jiang, B. H., Rue, E. A. and Semenza, G. L. (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl Acad. Sci. USA, 92, 5510-5514.
23. Forsythe, J. A., Jiang, B. H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D. and Semenza, G. L. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol., 16, 4604-4613.
24. Bjornsti, M. A. and Houghton, P. J. (2004) The TOR pathway: a target for cancer therapy. Nat. Rev. Cancer, 4, 335-348.
25. Jiang, B. H. and Liu, L. Z. (2008) Role of mTOR in anticancer drug resistance: perspectives for improved drug treatment. Drug Resist. Updat., 11, 63-76.
26. Baldo, P., Cecco, S., Giacomin, E., Lazzarini, R., Ros, B. and Marastoni, S. (2008) mTOR pathway and mTOR inhibitors as agents for cancer therapy. Curr. Cancer Drug Targets, 8, 647-665.
27. Liu, L. Z., Zheng, J. Z., Wang, X. R. and Jiang, B. H. (2008) Endothelial p70 S6 kinase 1 in regulating tumor angiogenesis. Cancer Res., 68, 8183-8188.
28. Skinner, H. D., Zheng, J. Z., Fang, J., Agani, F. and Jiang, B. H. (2004) Vascular endothelial growth factor transcriptional activation is mediated by hypoxia-inducible factor 1alpha, HDM2, and p70S6K1 in response to phosphatidylinositol 3-kinase/AKT signaling. J. Biol. Chem., 279, 45643-45651.
29. Li, W., Tan, D., Zhang, Z., Liang, J. J. and Brown, R. E. (2008) Activation of Akt-mTOR-p70S6K pathway in angiogenesis in hepatocellular carcinoma. Oncol. Rep., 20, 713-719.
30. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T. and Thun, M. J. (2008) Cancer statistics, 2008. CA Cancer J. Clin., 58, 71-96.
31. Slaby, O., Svoboda, M., Fabian, P., Smerdova, T., Knoflickova, D., Bednarikova, M., Nenutil, R. and Vyzula, R. (2007) Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology, 72, 397-402.
32. Schepeler, T., Reinert, J. T., Ostenfeld, M. S., Christensen, L. L., Silahtaroglu, A. N., Dyrskjot, L., Wiuf, C., Sorensen, F. J., Kruhoffer, M., Laurberg, S. et al. (2008) Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res., 68, 6416-6424.
33. Arndt, G. M., Dossey, L., Cullen, L. M., Lai, A., Druker, R., Eisbacher, M., Zhang, C., Tran, N., Fan, H., Retzlaff, K. et al. (2009) Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer, 9, 374.
34. Wang, S., Bian, C., Yang, Z., Bo, Y., Li, J., Zeng, L., Zhou, H. and Zhao, R. C. (2009) miR-145 inhibits breast cancer cell growth through RTKN. Int. J. Oncol., 34, 1461-1466.
35. Sachdeva, M. and Mo, Y. Y. (2010) MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res., 70, 378-387.
36. Larsson, E., Fredlund, F. P., Heldin, J., Barkefors, I., Bondjers, C., Genove, G., Arrondel, C., Gerwins, P., Kurschat, C., Schermer, B. et al. (2009) Discovery of microvascular miRNAs using public gene expression data: miR-145 is expressed in pericytes and is a regulator of Fli1. Genome Med., 1, 108.
37. Ostenfeld, M. S., Bramsen, J. B., Lamy, P., Villadsen, S. B., Fristrup, N., Sorensen, K. D., Ulhoi, B., Borre, M., Kjems, J., Dyrskjot, L. et al. (2010) miR-145 induces caspase-dependent and-independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors. Oncogene, 29, 1073-1084.
38. Cho, W. C., Chow, A. S. and Au, J. S. (2011) MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1. RNA. Biol., 8, 125-131.
39. Chiyomaru, T., Enokida, H., Tatarano, S., Kawahara, K., Uchida, Y., Nishiyama, K., Fujimura, L., Kikkawa, N., Seki, N. and Nakagawa, M. (2010) miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br. J. Cancer, 102, 883-891.
40. Chen, Z., Zeng, H., Guo, Y., Liu, P., Pan, H., Deng, A. and Hu, J. (2010) miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc. J. Exp. Clin. Cancer Res., 29, 151.
41. Gotte, M., Mohr, C., Koo, C. Y., Stock, C., Vaske, A. K., Viola, M., Ibrahim, S. A., Peddibhotla, S., Teng, Y. H., Low, J. Y. et al. (2010) miR-145-dependent targeting of junctional adhesion molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness. Oncogene, 29, 6569-6580.
42. Gregersen, L. H., Jacobsen, A. B., Frankel, L. B., Wen, J., Krogh, A. and Lund, A. H. (2010) MicroRNA-145 targets YES and STAT1 in colon cancer cells. PLoS ONE, 5, e8836.
43. Zhang, J., Guo, H., Qian, G., Ge, S., Ji, H., Hu, X. and Chen, W. (2010) MiR-145, a new regulator of the DNA fragmentation factor-45 (DFF45)-mediated apoptotic network. Mol. Cancer, 9, 211.
44. Zhang, J., Guo, H., Zhang, H., Wang, H., Qian, G., Fan, X., Hoffman, A. R., Hu, J. F. and Ge, S. (2011) Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene Friend leukemia virus integration 1 gene. Cancer, 117, 86-95.
45. Liu, L. Z., Hu, X. W., Xia, C., He, J., Zhou, Q., Shi, X., Fang, J. and Jiang, B. H. (2006) Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1alpha expression through activation of AKT and P70S6K1 in human ovarian cancer cells. Free Radic. Biol. Med, 41, 1521-1533.
46. Schmid, T., Jansen, A. P., Baker, A. R., Hegamyer, G., Hagan, J. P. and Colburn, N. H. (2008) Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion. Cancer Res., 68, 1254-1260.
47. Carayol, N., Katsoulidis, E., Sassano, A., Altman, J. K., Druker, B. J. and Platanias, L. C. (2008) Suppression of programmed cell death 4 (PDCD4) protein expression by BCR-ABL-regulated engagement of the mTOR/p70 S6 kinase pathway. J. Biol. Chem., 283, 8601-8610.
48. Zhou, Q., Liu, L. Z., Fu, B., Hu, X., Shi, X., Fang, J. and Jiang, B. H. (2007) Reactive oxygen species regulate insulin-induced VEGF and HIF-1alpha expression through the activation of p70S6K1 in human prostate cancer cells. Carcinogenesis, 28, 28-37.
49. Liu, L. Z., Fang, J., Zhou, Q., Hu, X., Shi, X. and Jiang, B. H. (2005) Apigenin inhibits expression of vascular endothelial growth factor and angiogenesis in human lung cancer cells: implication of chemoprevention of lung cancer. Mol. Pharmacol., 68, 635-643.
50. Xin, M., Small, E. M., Sutherland, L. B., Qi, X., McAnally, J., Plato, C. F., Richardson, J. A., Bassel-Duby, R. and Olson, E. N. (2009) MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev., 23, 2166-2178.
51. Zeng, L., Carter, A. D. and Childs, S. J. (2009) miR-145 directs intestinal maturation in zebrafish. Proc. Natl Acad. Sci. USA, 106, 17793-17798.
52. Sachdeva, M., Zhu, S., Wu, F., Wu, H., Walia, V., Kumar, S., Elble, R., Watabe, K. and Mo, Y. Y. (2009) p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc. Natl Acad. Sci. USA, 106, 3207-3212.
53. Spizzo, R., Nicoloso, M. S., Lupini, L., Lu, Y., Fogarty, J., Rossi, S., Zagatti, B., Fabbri, M., Veronese, A., Liu, X. et al. (2009) miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells. Cell Death. Differ., 17, 246-254.
54. Bandres, E., Cubedo, E., Agirre, X., Malumbres, R., Zarate, R., Ramirez, N., Abajo, A., Navarro, A., Moreno, I., Monzo, M. et al. (2006) Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol. Cancer, 5, 29.
55. Arndt, G. M., Dossey, L., Cullen, L. M., Lai, A., Druker, R., Eisbacher, M., Zhang, C., Tran, N., Fan, H., Retzlaff, K. et al. (2009) Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC. Cancer, 9, 374.
56. Semenza, G. L. (2010) Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene, 29, 625-634.